Inguinal lymph node dissection for penile cancer: a contemporary review.

Penile cancer inguinal lymph node metastasis (ILN metastasis) surgical oncology

Journal

Translational andrology and urology
ISSN: 2223-4691
Titre abrégé: Transl Androl Urol
Pays: China
ID NLM: 101581119

Informations de publication

Date de publication:
Dec 2020
Historique:
entrez: 18 1 2021
pubmed: 19 1 2021
medline: 19 1 2021
Statut: ppublish

Résumé

Penile cancer is an uncommon disease associated with significant psychological and physical morbidity. Penile cancer has an expectable pattern of spread in a stepwise fashion, from inguinal to pelvic lymph nodes (PLN) then distant spread. Patients with penile cancer have variable survival, with patients with a low burden of nodal metastatic disease having lasting survival with surgical management, however patients with a large amount of locoregional metastatic disease having a worse prognosis. The current management options for patients with metastatic lymph node disease in penile cancer aims to reduce the morbidity associated with radical inguinal lymph node (ILN) surgery with appropriate risk stratification to optimise oncological control of the disease. This article describes current challenges in managing the inguinal region in patients with penile squamous cell carcinoma (SCC).

Identifiants

pubmed: 33457292
doi: 10.21037/tau.2019.08.37
pii: tau-09-06-3210
pmc: PMC7807325
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

3210-3218

Informations de copyright

2020 Translational Andrology and Urology. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tau.2019.08.37). The series “Surgery for Urologic Cancers” was commissioned by the editorial office without any funding or sponsorship. The authors have no conflicts of interest to declare.

Références

Ann Surg Oncol. 2002 Mar;9(2):142-7
pubmed: 11888870
Ann R Coll Surg Engl. 2010 Jan;92(1):44-5
pubmed: 20056060
Surgeon. 2016 Apr;14(2):82-6
pubmed: 25444439
Urol Ann. 2012 Sep;4(3):150-3
pubmed: 23248520
Eur Urol. 2010 Nov;58(5):742-7
pubmed: 20800339
Curr Probl Cancer. 2015 May-Jun;39(3):126-36
pubmed: 26076979
J Urol. 1988 Aug;140(2):306-10
pubmed: 3398125
Eur Urol. 2009 May;55(5):1075-88
pubmed: 19264390
J Urol. 2001 Apr;165(4):1138-42
pubmed: 11257655
Cancer. 2010 Jun 15;116(12):2960-6
pubmed: 20564401
Transl Androl Urol. 2017 Oct;6(5):874-878
pubmed: 29184785
J Urol. 2014 Oct;192(4):1105-10
pubmed: 24747092
Urology. 2017 Aug;106:113-118
pubmed: 28450202
Histopathology. 2018 May;72(6):893-904
pubmed: 29105175
Urology. 2007 Apr;69(4):759-62
pubmed: 17445665
N Engl J Med. 2015 Nov 5;373(19):1803-13
pubmed: 26406148
J Urol. 2017 Mar;197(3 Pt 1):690-697
pubmed: 27697578
Eur J Cancer. 2013 Apr;49(6):1414-21
pubmed: 23231984
BJU Int. 2016 Feb;117(2):287-92
pubmed: 25395083
J Urol. 1996 Nov;156(5):1637-42
pubmed: 8863559
Cancer Causes Control. 2009 May;20(4):449-57
pubmed: 19082746
Clin Genitourin Cancer. 2016 Aug;14(4):323-30
pubmed: 26341040
J Urol. 2012 Oct;188(4):1176-80
pubmed: 22901575
Eur Urol. 2008 Oct;54(4):875-82
pubmed: 18243513
J Urol. 2014 Sep;192(3):760-4
pubmed: 24603104
Urol Oncol. 2019 Mar;37(3):201-208
pubmed: 30301700
Eur Urol. 2007 Aug;52(2):488-94
pubmed: 17316964
Urology. 2010 Aug;76(2 Suppl 1):S2-6
pubmed: 20691882
Scand J Urol Nephrol. 2012 Oct;46(5):319-25
pubmed: 22989150
Ann R Coll Surg Engl. 2012 Jul;94(5):344-6
pubmed: 22943231
World J Urol. 2009 Apr;27(2):205-12
pubmed: 18762945
J Natl Compr Canc Netw. 2013 May 1;11(5):594-615
pubmed: 23667209
BJU Int. 2006 Sep;98(3):526-31
pubmed: 16925747
Urol Clin North Am. 1992 May;19(2):211-9
pubmed: 1574812
J Urol. 1987 May;137(5):880-2
pubmed: 3573181
J Clin Oncol. 2010 Aug 20;28(24):3851-7
pubmed: 20625118
J Urol. 2007 Jun;177(6):2157-61
pubmed: 17509308
J Urol. 2002 Dec;168(6):2418-21; discussion 2421
pubmed: 12441930
Acta Oncol. 1988;27(6b):823-4
pubmed: 2466471
Eur Urol. 2004 Jun;45(6):761-5; discussion 765-6
pubmed: 15149749
Ann R Coll Surg Engl. 2012 Apr;94(3):204-9
pubmed: 22507729
J Urol. 1996 Feb;155(2):560-3
pubmed: 8558660
Cancer. 1977 Feb;39(2):456-66
pubmed: 837331
Eur Urol. 2008 Jul;54(1):161-8
pubmed: 18440124
J Urol. 2007 Mar;177(3):953-7; discussion 958
pubmed: 17296386
Transl Androl Urol. 2018 Oct;7(5):887-902
pubmed: 30456192
Ann Surg Oncol. 2018 Oct;25(11):3404-3412
pubmed: 30039324
J Urol. 2018 Jun;199(6):1518-1525
pubmed: 29307685
Surg Gynecol Obstet. 1948 Dec;87(6):679-94
pubmed: 18120502
J Urol. 2005 Mar;173(3):816-9
pubmed: 15711276
J Urol. 2012 Jan;187(1):25-31
pubmed: 22088350
J Robot Surg. 2019 Feb;13(1):1-8
pubmed: 29730734
BJU Int. 2006 Jun;97(6):1225-8
pubmed: 16686716
J Urol. 2002 Apr;167(4):1638-42
pubmed: 11912379
Arch Dermatol. 2009 Aug;145(8):950-2
pubmed: 19687438

Auteurs

Jiasian Teh (J)

Department of Surgery, Austin Hospital, University of Melbourne, Melbourne, Victoria, Australia.
Young Urology Researchers Organisation (YURO), Melbourne, Victoria, Australia.
Division of Cancer Surgery, Peter MacCallum Centre, Melbourne, Victoria, Australia.
Division of Cancer Research, Peter MacCallum Centre, Melbourne, Victoria, Australia.

Catriona Duncan (C)

Department of Surgery, Austin Hospital, University of Melbourne, Melbourne, Victoria, Australia.
Young Urology Researchers Organisation (YURO), Melbourne, Victoria, Australia.

Liang Qu (L)

Young Urology Researchers Organisation (YURO), Melbourne, Victoria, Australia.

Glen Guerra (G)

Division of Cancer Surgery, Peter MacCallum Centre, Melbourne, Victoria, Australia.
Division of Cancer Research, Peter MacCallum Centre, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.

Vignesh Narasimhan (V)

Division of Cancer Surgery, Peter MacCallum Centre, Melbourne, Victoria, Australia.
Division of Cancer Research, Peter MacCallum Centre, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.

Toan Pham (T)

Division of Cancer Surgery, Peter MacCallum Centre, Melbourne, Victoria, Australia.
Division of Cancer Research, Peter MacCallum Centre, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.

Nathan Lawrentschuk (N)

Department of Surgery, Austin Hospital, University of Melbourne, Melbourne, Victoria, Australia.
Division of Cancer Surgery, Peter MacCallum Centre, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
Olivia Newton-John Cancer Research Institute, Austin Hospital, Melbourne, Victoria, Australia.

Classifications MeSH